Showing results (431-440 of 528) with videos related to
Sort By:
Pageof 53
Current Microbiology|July 15, 1998
The effect of galE gene inactivation on lipopolysaccharide profile of Helicobacter pyloriD H Kwon, J S Woo, C L Perng, et al.Alimentary Pharmacology & Therapeutics|November 14, 1997
Clarithromycin, amoxycillin and H2-receptor antagonist therapy for Helicobacter pylori peptic ulcer disease in KoreaT Breuer, J G Kim, H M el-Zimaity, et al.Alimentary Pharmacology & Therapeutics|April 1, 1995
Metronidazole, omeprazole and clarithromycin: an effective combination therapy for Helicobacter pylori infectionM M Yousfi, H M el-Zimaity, M T al-Assi, et al.Scandinavian Journal of Gastroenterology|January 1, 1997
Expression of mRNA for interferon-gamma, interleukin-10, and interleukin-12 (p40) in normal gastric mucosa and in mucosa infected with Helicobacter pyloriR A Karttunen, T J Karttunen, M M Yousfi, et al.Gastroenterology|September 11, 1992
Selection of the chimpanzee over the baboon as a model for Helicobacter pylori infectionS L Hazell, J W Eichberg, D R Lee, et al.Alimentary Pharmacology & Therapeutics|January 6, 2006
Rabeprazole containing triple therapy to eradicate Helicobacter pylori infection on the Texas-Mexican borderV M Cardenas, D Y Graham, H M T El-Zimaity, et al.The American Journal of Gastroenterology|December 1, 1993
Acid secretion and serum gastrin in normal subjects and patients with duodenal ulcer: the role of Helicobacter pyloriW L Peterson, C C Barnett, D J Evans, et al.Advances in Experimental Medicine and Biology|January 1, 1997
Virus-like particle vaccines for mucosal immunizationM K Estes, J M Ball, S E Crawford, et al.Alimentary Pharmacology & Therapeutics|May 21, 2003
Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradicationD Y Graham, F Hammoud, H M T El-Zimaity, et al.Gastroenterology|August 1, 1983
Natural history of benign esophageal stricture treated by dilatationD J Patterson, D Y Graham, J L Smith, et al.Pageof 53